Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
zinc finger protein Y-linked | 0.716 | 0.308 | 0.69 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
X-ray sensitivity | 0.716 | 0.500 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1988 | 1994 | |||||||||
|
H3 histone pseudogene 5 | 0.656 | 0.538 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1994 | 1994 | |||||||||
|
DNA polymerase epsilon 4, accessory subunit | 0.653 | 0.538 | 7.0E-04 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1994 | 1994 | ||||||||
|
protein tyrosine phosphatase non-receptor type 7 | 0.736 | 0.385 | 9.4E-14 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
DNA polymerase delta 4, accessory subunit | 0.647 | 0.577 | 0.15 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1994 | 1994 | ||||||||
|
BCR pseudogene 3 | 0.705 | 0.269 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | |||||||||
|
ATR interacting protein | 0.666 | 0.692 | 2.0E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
complement C3d receptor 2 | 0.556 | 0.654 | 4.7E-19 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1991 | 1995 | ||||||||
|
ABR activator of RhoGEF and GTPase | 0.650 | 0.500 | 0.63 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
norrin cystine knot growth factor NDP | 0.566 | 0.692 | 0.65 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
orosomucoid 1 | 0.608 | 0.731 | 1.1E-05 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
pantothenate kinase 1 | 0.743 | 0.308 | 2.7E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
solute carrier family 7 member 4 | 0.666 | 0.423 | 2.8E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
Hyperreflexia | 0.695 | 0.192 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1994 | 1996 | |||||||||
|
Leukemia, acute lymphocytic, susceptibility to, 1 | 0.636 | 0.269 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 1996 | |||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
interferon alpha 17 | 0.636 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
laminin subunit beta 1 | 0.615 | 0.654 | 5.1E-22 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
neurofilament heavy | 0.588 | 0.769 | 2.7E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
proteasome 20S subunit beta 6 | 0.561 | 0.731 | 1.6E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
sulfotransferase family 1A member 2 | 0.890 | 0.115 | 3.7E-12 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
seizure related 6 homolog like 2 | 0.769 | 0.231 | 0.12 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 1997 | ||||||||
|
serine/threonine kinase 16 | 0.805 | 0.231 | 1.2E-04 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 1995 | 1997 | ||||||||
|
collectin subfamily member 10 | 0.621 | 0.692 | 2.6E-03 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 1997 | 1997 |